Venlafaxine ER

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Social Anxiety Disorder

Conditions

Social Anxiety Disorder

Trial Timeline

Dec 1, 1999 → Jun 1, 2003

NCT ID

NCT00238719

About Venlafaxine ER

Venlafaxine ER is a phase 3 stage product being developed by Pfizer for Social Anxiety Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00238719. Target conditions include Social Anxiety Disorder.

What happened to similar drugs?

7 of 15 similar drugs in Social Anxiety Disorder were approved

Approved (7) Terminated (4) Active (5)

✅Cariprazine + PlaceboAbbVieApproved

✅QuetiapineAstraZenecaApproved

❌quetiapineAstraZenecaPhase 3

🔄Seroquel + Sugar PillAstraZenecaPhase 3

✅quetiapineAstraZenecaApproved

✅Pristiq + PlaceboPfizerApproved

✅Sertraline + PlaceboPfizerApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01485887	Phase 3	Completed	Jan 1, 2012	Jan 1, 2014	Major Depressive Disorder
NCT00401726	Approved	Completed	Jun 1, 2006	Oct 1, 2007	Depressive Disorder, Major
NCT00044772	Phase 3	Completed	Nov 1, 2001	Apr 1, 2003	Panic Disorder
NCT00038896	Phase 3	Completed	Apr 1, 2001	Dec 1, 2002	Panic Disorder
NCT00046020	Approved	Completed	Aug 1, 2000	Oct 1, 2005	Depressive Disorder, Major
NCT00238719	Phase 3	Completed	Dec 1, 1999	Jun 1, 2003	Social Anxiety Disorder

Competing Products

20 competing products in Social Anxiety Disorder

See all competitors

Product	Company	Stage	Hype Score
LY686017 + paroxetine + placebo	Eli Lilly	Phase 2	35
atomoxetine + placebo	Eli Lilly	Phase 2/3	38
ONO-1110 + Placebo	Ono Pharmaceutical	Phase 2	39
Cariprazine + Placebo	AbbVie	Approved	43
Quetiapine	AstraZeneca	Approved	43
quetiapine	AstraZeneca	Phase 3	32
quetiapine	AstraZeneca	Phase 2/3	38
Seroquel + Sugar Pill	AstraZeneca	Phase 3	40
quetiapine	AstraZeneca	Approved	43
Pristiq + Placebo	Pfizer	Approved	43
Ziprasidone + Sertraline	Pfizer	Phase 2	35
Sertraline + Placebo	Pfizer	Approved	35
Nefazodone	Bristol Myers Squibb	Approved	43
Escitalopram	Lundbeck	Approved	40
Cipralex + Placebo	Lundbeck	Phase 2	32
BHV-0223 + Placebo	Biohaven	Phase 2/3	32
VQW-765 + Placebo	Vanda Pharmaceuticals	Phase 3	37
PH94B	Vistagen Therapeutics	Phase 3	22
Fasedienol Nasal Spray - Placebo Nasal Spray + Fasedienol Nasal Spray - Fasedienol Nasal Spray + Placebo Nasal Spray - Placebo Nasal Spray	Vistagen Therapeutics	Phase 2	32
PH94B Nasal Spray + Placebo Nasal Spray	Vistagen Therapeutics	Phase 3	22